PD-166793 2265 leading to apoptosis without the

leading to apoptosis without the need for a Smac mimetic in a variety of cancer cell lines

Smiles: CC1(C=CC=C(C)C(O)=O)OC(=O)C23CC=C(CCC2(O)C1CC3)C(=O)OC

CC1N=CSC=1C1=CC=C(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)CCCCN)C(C)(C)C)C=C1

InChi: InChI=1S/C23H24FN5O/c1-15(25)14-30-20-8-6-17(7-9-20)21-13-26-23-11-10-22(28-29(21)23)27-16(2)18-4-3-5-19(24)12-18/h3-13

which shows potent activities against the main microorganisms isolated from skin and soft tissue infections

PD-166793 2265 leading to apoptosis without thePD 166793 is a potent, selective, orally active and widebroad spectrum inhibitor of MMP, exhibiting nanomolar potency against MMP 2, MMP 3 and MMP 13 (IC50=4, 7, and 8 nM, respectively) and micromolar potency vs MMP 1, 7 and 9 (IC50=6. 0, 7. 2, and 7. 9 M, respectively). PD 166793 can attenuate left ventricular remodeling and dysfunction in a rat model of progressive heart failure. Product information CAS Number: 199850 67 4 Molecular Weight: 412. 30